Centaur Labs
Series B in 2024
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Headlight
Series A in 2024
Headlight is a mental health firm that aims to change the way mental health services are delivered. Headlight is reinventing mental health care with its clinician-centered methodology, new technology, and commitment to accessibility and cost.
Founded in 2013, Aluna develops a portable spirometry device paired with an interactive iPhone game. Its health platform helps users track asthma symptoms, monitor medication, and provides real-time data sharing with doctors for personalized treatment plans.
August Health
Series A in 2022
August Health develops an integrated electronic health record platform for senior living communities. Their technology enables caregivers to shift from reactive to proactive care, offering features like digital move-ins, medication tracking, real-time insights, billing solutions, and mobile daily care tracking.
Onechip Bioelectronics
Series B in 2022
Wanzhong Yixin Biotechnology is a developer of semiconductor integrated circuit biosensor chips and other related devices. The company's biosensor chip products are used in emerging fields such as genetic testing, water quality monitoring, and environmental protection IoT monitoring.
Qiyi Medical
Seed Round in 2022
Qiyi Medical concentrates on the development of disease management systems and digital diagnosis and treatment products. It solves the core pain points of diagnosis, treatment, and management of chronic respiratory diseases.
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.
GLZCARES is a one-stop Internet overseas medical service platform, dedicated to providing overseas medical services for domestic users
NeuraMatrix
Series A in 2021
NeuraMatrix is an innovative developer of brain-computer interface technology, specializing in advanced neural interfaces that facilitate communication between humans and computers. The company's comprehensive approach includes both hardware and software solutions, aiming to enhance human interaction with technology and advance research in brain science and neurological diseases. NeuraMatrix focuses on improving diagnosis, treatment, and drug development for neurological conditions while leveraging the significant commercial potential of its brain-computer interface technologies. Recently, the company secured significant funding to support research and development efforts, including the update of R&D equipment, mass production of chips, product iterations, and market promotion. Through its pioneering efforts, NeuraMatrix is positioned to influence the future of neuroscience research and its practical applications.
RootPath Genomics
Series B in 2021
RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.
Centaur Labs
Series A in 2021
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Scivita Medical
Series B in 2021
Scivita Medical is a high-tech enterprise specializing in optical diagnosis and treatment, as well as the development of multidimensional imaging technologies and high-performance materials. The company focuses on precision manufacturing for minimally invasive medical procedures and is recognized for its advancements in endoscopy technology. Scivita Medical offers a range of products that include flexible and rigid endoscopes, featuring innovations such as ultra-high-definition visualization, 3D imaging, and specialized light visualization techniques, including fluorescence. Its portfolio encompasses various medical devices, including 4K medical endoscope camera systems, integrated endoscope systems, and single-use electronic instruments like hysteroscopes, bladder pyeloscopes, and bronchoscopes. These products are designed to provide healthcare professionals with efficient tools for diagnosis and treatment, enhancing the capabilities of modern endoscopic procedures.
Reigncom is a company focused on the research, development, manufacturing, and distribution of diagnostic medical devices and in vitro diagnostic (IVD) reagent kits. The company specializes in a range of products, including rapid test products, latex-enhanced immunoturbidimetry products, and autoimmune antibodies. Reigncom is dedicated to advancing technology innovation through various projects supported by different funding sources, ensuring a strong commitment to the continuous improvement and expansion of its product offerings and related services in the healthcare sector.
Scivita Medical
Series A in 2021
Scivita Medical is a high-tech enterprise specializing in optical diagnosis and treatment, as well as the development of multidimensional imaging technologies and high-performance materials. The company focuses on precision manufacturing for minimally invasive medical procedures and is recognized for its advancements in endoscopy technology. Scivita Medical offers a range of products that include flexible and rigid endoscopes, featuring innovations such as ultra-high-definition visualization, 3D imaging, and specialized light visualization techniques, including fluorescence. Its portfolio encompasses various medical devices, including 4K medical endoscope camera systems, integrated endoscope systems, and single-use electronic instruments like hysteroscopes, bladder pyeloscopes, and bronchoscopes. These products are designed to provide healthcare professionals with efficient tools for diagnosis and treatment, enhancing the capabilities of modern endoscopic procedures.
NeuraMatrix
Seed Round in 2021
NeuraMatrix is an innovative developer of brain-computer interface technology, specializing in advanced neural interfaces that facilitate communication between humans and computers. The company's comprehensive approach includes both hardware and software solutions, aiming to enhance human interaction with technology and advance research in brain science and neurological diseases. NeuraMatrix focuses on improving diagnosis, treatment, and drug development for neurological conditions while leveraging the significant commercial potential of its brain-computer interface technologies. Recently, the company secured significant funding to support research and development efforts, including the update of R&D equipment, mass production of chips, product iterations, and market promotion. Through its pioneering efforts, NeuraMatrix is positioned to influence the future of neuroscience research and its practical applications.
Weimai is a developer of a health application platform that aims to enhance medical and health services. The platform offers various features, including Internet-based appointment scheduling, maternal and child disease management, grading diagnosis and treatment, remote diagnosis, and medical records management. By cooperating with local hospitals, Weimai provides a range of services such as medical consultations, internet diagnosis and treatment, health management, and on-site medical and nursing assistance. This integration not only facilitates access to medical care for patients but also helps hospitals improve their operational efficiency. Ultimately, Weimai's goal is to deliver a comprehensive family doctor application that brings medical expertise into homes.
GeneCast Biotechnology
Series E in 2020
GeneCast Biotechnology Co., Ltd. is a Beijing-based company founded in 2014, specializing in gene research and cancer diagnostics. The company offers a technology platform for cell-free DNA next-generation sequencing (NGS) tests, which include companion diagnostics, genetic profiling, prognosis, and monitoring for various solid tumors. GeneCast provides solutions for cancer treatment and genetic testing, focusing on tumors such as lung, colorectal, liver, and breast cancers. Its non-invasive diagnostic methods leverage high-throughput sequencing and bioinformatics to enable personalized medicine, aiming to improve patient outcomes and quality of life. The company collaborates with hospitals and research institutions to advance its capabilities in detecting tumors and cancer-related genes in blood.
UP Clinic
Series B in 2020
UP Clinic is an orthopedic rehabilitation center specializing in the diagnosis and treatment of sports medicine and musculoskeletal conditions. The clinic caters to sports enthusiasts, orthopedic patients, postoperative individuals, and those experiencing sub-health issues. It offers a comprehensive range of services, including medical treatment, rehabilitation, and specialized orthopedic care. With a team of professional medical experts and advanced equipment, UP Clinic emphasizes a patient-centered approach and adheres to evidence-based medicine, ensuring high-quality care tailored to individual needs.
Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.
RootPath Genomics
Series A in 2020
RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.
Lansion Biotechnology
Series C in 2019
Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices. With its advanced technology concept, Lansionbio provides equioment, reagents and services to world-wild clients according to their needs.
GeneCast Biotechnology
Series D in 2019
GeneCast Biotechnology Co., Ltd. is a Beijing-based company founded in 2014, specializing in gene research and cancer diagnostics. The company offers a technology platform for cell-free DNA next-generation sequencing (NGS) tests, which include companion diagnostics, genetic profiling, prognosis, and monitoring for various solid tumors. GeneCast provides solutions for cancer treatment and genetic testing, focusing on tumors such as lung, colorectal, liver, and breast cancers. Its non-invasive diagnostic methods leverage high-throughput sequencing and bioinformatics to enable personalized medicine, aiming to improve patient outcomes and quality of life. The company collaborates with hospitals and research institutions to advance its capabilities in detecting tumors and cancer-related genes in blood.
Weimai is a developer of a health application platform that aims to enhance medical and health services. The platform offers various features, including Internet-based appointment scheduling, maternal and child disease management, grading diagnosis and treatment, remote diagnosis, and medical records management. By cooperating with local hospitals, Weimai provides a range of services such as medical consultations, internet diagnosis and treatment, health management, and on-site medical and nursing assistance. This integration not only facilitates access to medical care for patients but also helps hospitals improve their operational efficiency. Ultimately, Weimai's goal is to deliver a comprehensive family doctor application that brings medical expertise into homes.
CTRL-Labs
Venture Round in 2019
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.
Ruixin Smart Medical
Series A in 2019
Ruixin Smart Medical develops real-time monitoring equipment for the detection of cardiovascular and cerebrovascular diseases. It is researching and developing intelligent medical platforms based on artificial intelligence, simulation, and cloud computing, so as to deeply mine the information in medical data to more accurately assess the condition and guide treatment.
The company was founded in 2017 and is headquartered in Shenzhen.
Weimai is a developer of a health application platform that aims to enhance medical and health services. The platform offers various features, including Internet-based appointment scheduling, maternal and child disease management, grading diagnosis and treatment, remote diagnosis, and medical records management. By cooperating with local hospitals, Weimai provides a range of services such as medical consultations, internet diagnosis and treatment, health management, and on-site medical and nursing assistance. This integration not only facilitates access to medical care for patients but also helps hospitals improve their operational efficiency. Ultimately, Weimai's goal is to deliver a comprehensive family doctor application that brings medical expertise into homes.
UP Clinic
Series A in 2018
UP Clinic is an orthopedic rehabilitation center specializing in the diagnosis and treatment of sports medicine and musculoskeletal conditions. The clinic caters to sports enthusiasts, orthopedic patients, postoperative individuals, and those experiencing sub-health issues. It offers a comprehensive range of services, including medical treatment, rehabilitation, and specialized orthopedic care. With a team of professional medical experts and advanced equipment, UP Clinic emphasizes a patient-centered approach and adheres to evidence-based medicine, ensuring high-quality care tailored to individual needs.
Chemclin
Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its service offerings encompass clinical inspection instruments, various types of auxiliary reagents, technical support, management and certification, as well as the operation of independent medical laboratories. Chemclin is committed to introducing advanced diagnostic products and services to the Chinese market, thereby enhancing the capabilities of clinical diagnostics in the region.
Si'ao Biotechnology
Series A in 2018
Si'ao Biotechnology engages in the development and production of genetic engineering vaccines and test kits.
GrandOmics
Series B in 2018
GrandOmics is a biotechnology company that specializes in molecular diagnostics and genetic testing services, primarily targeting single-gene diseases. The company develops and utilizes advanced sequencing technologies, including single-molecule, real-time sequencing, to enhance disease detection. GrandOmics offers a comprehensive platform known as GrandBox, which integrates clinical sample management, data standard analysis, and visualization reporting. This platform serves as a centralized solution for clinical laboratories, enabling efficient management and analysis of genetic disease sequencing data. Through its innovative approach, GrandOmics aims to provide accurate, reliable, and scientifically rigorous genetic testing services that support both research and clinical applications.
CTRL-Labs
Series B in 2018
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.
23Mofang is a company specializing in genetic testing services tailored for the Chinese population. It manufactures saliva-based testing kits that allow users to assess their ancestral origins, genetic risks, and traits. By evaluating samples, the company provides detailed reports through a mobile application, facilitating early intervention for potential health issues. Furthermore, 23Mofang integrates Internet technology with genetic testing to create a comprehensive database of life data, with the mission of enhancing health benefits for individuals and communities. The company aims to establish itself as a reliable technology enterprise in the field of genetic testing and life data analysis.
GeneCast Biotechnology
Series C in 2018
GeneCast Biotechnology Co., Ltd. is a Beijing-based company founded in 2014, specializing in gene research and cancer diagnostics. The company offers a technology platform for cell-free DNA next-generation sequencing (NGS) tests, which include companion diagnostics, genetic profiling, prognosis, and monitoring for various solid tumors. GeneCast provides solutions for cancer treatment and genetic testing, focusing on tumors such as lung, colorectal, liver, and breast cancers. Its non-invasive diagnostic methods leverage high-throughput sequencing and bioinformatics to enable personalized medicine, aiming to improve patient outcomes and quality of life. The company collaborates with hospitals and research institutions to advance its capabilities in detecting tumors and cancer-related genes in blood.
12 Sigma Technologies
Series B in 2017
12 Sigma Technologies, founded in April 2015, is an innovative healthcare company that focuses on modern medical image diagnosis and medical data analysis. The company leverages advanced artificial intelligence technology to enhance medical imaging applications, recognizing the significant potential at the intersection of AI and healthcare. It has established partnerships with General Electric to collaboratively develop smart diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, 12 Sigma has engaged with over 50 top-tier hospitals in China to facilitate applied medical diagnostics, technical research, and clinical trials, underscoring its commitment to advancing healthcare through cutting-edge technology.
CTRL-Labs
Series A in 2017
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.
Distinct HealthCare
Series C in 2017
Distinct HealthCare is a private healthcare provider operating approximately 20 clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. Founded in 2012, the company focuses on delivering patient-oriented and quality-assured medical services. Its clinics offer a range of medical specialties, including pediatrics, internal medicine, gynecology, and family medicine, addressing various health issues such as common colds, diabetes, and chronic kidney disease. Distinct HealthCare also provides emergency support, facilitates referrals to specialists, and conducts essential examinations and laboratory tests. Additionally, the company offers nursing services and well-baby plans, ensuring comprehensive care for patients. By employing doctors from prestigious medical institutions, Distinct HealthCare emphasizes appropriate treatment suggestions while minimizing unnecessary antibiotic prescriptions and examinations. The company has established a strategic partnership with Tencent Holdings Limited to enhance its service delivery.
BOSHI is a patient information management and data analysis platform.
12 Sigma Technologies
Series A in 2017
12 Sigma Technologies, founded in April 2015, is an innovative healthcare company that focuses on modern medical image diagnosis and medical data analysis. The company leverages advanced artificial intelligence technology to enhance medical imaging applications, recognizing the significant potential at the intersection of AI and healthcare. It has established partnerships with General Electric to collaboratively develop smart diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, 12 Sigma has engaged with over 50 top-tier hospitals in China to facilitate applied medical diagnostics, technical research, and clinical trials, underscoring its commitment to advancing healthcare through cutting-edge technology.
Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.
TopGene is a biotechnology company based in Guangzhou, China, established in 2014. It specializes in genomics technology applied to human medicine and life sciences, focusing on genetic testing, molecular diagnostics, and companion diagnostics for various diseases, including chromosomal disorders, hereditary deafness, metabolic diseases in newborns, and multiple cancer types. TopGene offers next-generation sequencing, DNA/RNA extraction services, and targeted re-sequencing to a diverse clientele, including academic institutions, biotechnology firms, government agencies, and pharmaceutical companies. The company emphasizes a patient-centered approach and aims to enhance human health through integrated services that combine scientific research with clinical applications. By promoting the clinical application of precision medicine, TopGene contributes to advancements in the fields of genetics and healthcare both in China and internationally.
GrandOmics
Venture Round in 2016
GrandOmics is a biotechnology company that specializes in molecular diagnostics and genetic testing services, primarily targeting single-gene diseases. The company develops and utilizes advanced sequencing technologies, including single-molecule, real-time sequencing, to enhance disease detection. GrandOmics offers a comprehensive platform known as GrandBox, which integrates clinical sample management, data standard analysis, and visualization reporting. This platform serves as a centralized solution for clinical laboratories, enabling efficient management and analysis of genetic disease sequencing data. Through its innovative approach, GrandOmics aims to provide accurate, reliable, and scientifically rigorous genetic testing services that support both research and clinical applications.
Meet you is a female health management app that provides women's menstrual management consulting services. The app is providing mothers-to-be with rich pregnancy knowledge and intimate pregnancy reminders. Record the moment of baby growth and provide scientific advice on baby growth to mothers. At the same time, it provides girls with health, emotion, weight loss, beauty, and shopping knowledge posts, as well as a built-in real-girl communication area to accompany women during every important period.
Wingspan is a company dedicated to advancing artificial intelligence in the healthcare sector, primarily through the development of a cloud-based medical imaging diagnostic platform. The company aims to transform traditional medical imaging services by leveraging mobile Internet technology to deliver comprehensive medical image services. Utilizing deep learning networks, Wingspan's systems analyze millions of scans to automatically recognize and identify diseases, thereby enhancing the diagnostic capabilities of healthcare professionals. This innovation not only facilitates real-time, accurate disease analysis and diagnosis but also aims to reduce the overall cost of medical care for patients, contributing to more effective healthcare delivery.
TOPSKY GROUP
Angel Round in 2015
TOPSKY is a physical examination center management system, occupational physical examination management system, intelligent inspection guidance system, a physical examination center, group examination appointment scheduling system, and a post-examination health management system. Their customers' inquiries are addressed through phone, email, and online applications.
ET Healthcare
Series B in 2015
ET Healthcare is a medical diagnostics company focused on automated immunodiagnostics. It develops central laboratory analyzers and near-patient testing solutions, with the Pylon Immunochemistry System designed to bring immunoassay performance closer to point-of-care. The system integrates central laboratory capabilities for immunoassays addressing inflammation, cardiac function, fertility, infectious diseases, and tumors, and includes BNP Immunoassay for heart failure management. The company operates from Palo Alto, California, with offices in Shanghai and manufacturing facilities in Suzhou, China. Its products aim to reduce facility space, plumbing, electricity needs, and staffing requirements while enabling high-sensitivity assays and streamlined blood analysis for a range of clinical settings, including hospitals and clinics.
ETComm is a biotech firm focused on developing compact digital health products for hospitals. The company specializes in creating innovative digital health solutions such as digital electrocardiographs, body fat measurement instruments, and Bluetooth blood pressure monitors. These products are designed to provide reliable tools for medical practitioners to enhance patient health. ETComm also offers a community smart medical service solution that acts as a health gatekeeper, automatically linking various types of electronic gear without manual operation. Additionally, the company provides direct health product OEM services, technical support, and background data analysis services through its industry integrators.
Vdaifu is a digital healthcare platform based in China that specializes in online bookings for pediatric healthcare services and doctors. By integrating medical big data from existing patients, the company offers a range of services including disease management, health checkups, and public health initiatives. This comprehensive approach not only enhances the quality of medical services available to patients but also improves operational efficiency for healthcare providers. Through its innovative platform, Vdaifu aims to streamline the healthcare experience for families and ensure better health outcomes for children.
Distinct HealthCare
Series B in 2015
Distinct HealthCare is a private healthcare provider operating approximately 20 clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. Founded in 2012, the company focuses on delivering patient-oriented and quality-assured medical services. Its clinics offer a range of medical specialties, including pediatrics, internal medicine, gynecology, and family medicine, addressing various health issues such as common colds, diabetes, and chronic kidney disease. Distinct HealthCare also provides emergency support, facilitates referrals to specialists, and conducts essential examinations and laboratory tests. Additionally, the company offers nursing services and well-baby plans, ensuring comprehensive care for patients. By employing doctors from prestigious medical institutions, Distinct HealthCare emphasizes appropriate treatment suggestions while minimizing unnecessary antibiotic prescriptions and examinations. The company has established a strategic partnership with Tencent Holdings Limited to enhance its service delivery.
Meet you is a female health management app that provides women's menstrual management consulting services. The app is providing mothers-to-be with rich pregnancy knowledge and intimate pregnancy reminders. Record the moment of baby growth and provide scientific advice on baby growth to mothers. At the same time, it provides girls with health, emotion, weight loss, beauty, and shopping knowledge posts, as well as a built-in real-girl communication area to accompany women during every important period.
Vdaifu is a digital healthcare platform based in China that specializes in online bookings for pediatric healthcare services and doctors. By integrating medical big data from existing patients, the company offers a range of services including disease management, health checkups, and public health initiatives. This comprehensive approach not only enhances the quality of medical services available to patients but also improves operational efficiency for healthcare providers. Through its innovative platform, Vdaifu aims to streamline the healthcare experience for families and ensure better health outcomes for children.
eyar provides medical information services for oral, reproductive health and related fields.
BOZWIN is engaged in the research and development, production, and sales of medical imaging products. They provide general imaging services in different scenarios, including routine outpatient clinics, fever clinics, emergency centers, physical examination centers, radiotherapy centers, and inpatient buildings.
Meet you is a female health management app that provides women's menstrual management consulting services. The app is providing mothers-to-be with rich pregnancy knowledge and intimate pregnancy reminders. Record the moment of baby growth and provide scientific advice on baby growth to mothers. At the same time, it provides girls with health, emotion, weight loss, beauty, and shopping knowledge posts, as well as a built-in real-girl communication area to accompany women during every important period.
ET Healthcare
Series A in 2014
ET Healthcare is a medical diagnostics company focused on automated immunodiagnostics. It develops central laboratory analyzers and near-patient testing solutions, with the Pylon Immunochemistry System designed to bring immunoassay performance closer to point-of-care. The system integrates central laboratory capabilities for immunoassays addressing inflammation, cardiac function, fertility, infectious diseases, and tumors, and includes BNP Immunoassay for heart failure management. The company operates from Palo Alto, California, with offices in Shanghai and manufacturing facilities in Suzhou, China. Its products aim to reduce facility space, plumbing, electricity needs, and staffing requirements while enabling high-sensitivity assays and streamlined blood analysis for a range of clinical settings, including hospitals and clinics.
Meet you is a female health management app that provides women's menstrual management consulting services. The app is providing mothers-to-be with rich pregnancy knowledge and intimate pregnancy reminders. Record the moment of baby growth and provide scientific advice on baby growth to mothers. At the same time, it provides girls with health, emotion, weight loss, beauty, and shopping knowledge posts, as well as a built-in real-girl communication area to accompany women during every important period.
TechMed Healthcare
Venture Round in 2013
TechMed Healthcare is a modern healthcare organization committed to promoting preventive healthcare as a fundamental aspect of well-being. The company emphasizes the importance of understanding one’s health status and potential disease susceptibility, particularly in the context of today's demanding lifestyles and the overwhelming availability of health information. By utilizing advanced technology, TechMed Healthcare aims to facilitate accurate diagnostics and early intervention, ultimately preventing diseases and promoting overall health. The organization operates a pathology chain that provides essential laboratory testing, diagnostic, and imaging services within hospital premises, ensuring timely delivery of test results to healthcare providers. Staffed by a team of highly qualified medical professionals, TechMed Healthcare is dedicated to making quality healthcare accessible and affordable, underscoring its belief that health is vital for happiness and fitness.
Centre for Sight
Venture Round in 2013
Centre for Sight, established in 1996, is a leading eye care provider in India, headquartered in New Delhi with additional facilities in the city. The company specializes in a wide range of eye care services, including cataract and LASIK surgery, retina and glaucoma treatment, cornea and pediatric ophthalmology, and oculoplasty and facial aesthetics. Centre for Sight is committed to patient-centric care, offering personalized treatment plans and comprehensive services from basic diagnostics to complex surgical procedures, all under one roof.
Distinct HealthCare
Series A in 2012
Distinct HealthCare is a private healthcare provider operating approximately 20 clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. Founded in 2012, the company focuses on delivering patient-oriented and quality-assured medical services. Its clinics offer a range of medical specialties, including pediatrics, internal medicine, gynecology, and family medicine, addressing various health issues such as common colds, diabetes, and chronic kidney disease. Distinct HealthCare also provides emergency support, facilitates referrals to specialists, and conducts essential examinations and laboratory tests. Additionally, the company offers nursing services and well-baby plans, ensuring comprehensive care for patients. By employing doctors from prestigious medical institutions, Distinct HealthCare emphasizes appropriate treatment suggestions while minimizing unnecessary antibiotic prescriptions and examinations. The company has established a strategic partnership with Tencent Holdings Limited to enhance its service delivery.
Edan Instruments
Series A in 2008
Edan Instruments, Inc. is a China-based company specializing in the design, manufacture, research, and development of medical electronic instruments. Established in 2002, the company offers a diverse range of products, including diagnostic ECG devices, patient monitoring systems, obstetrics and gynecology equipment, ultrasound imaging technology, in-vitro diagnostics, and veterinary instruments. Edan Instruments is committed to innovation and has a team of experienced engineers, alongside a workforce that includes professionals from various academic backgrounds. The company has demonstrated impressive growth, maintaining an annual growth rate of nearly 50%, which underscores its stable development in the medical equipment sector.
Revenio Group
Venture Round in 2000
Revenio Group is a health technology company focused on ophthalmology. It develops and commercializes ophthalmic diagnostic devices, including intraocular pressure measurement tonometers, and perimeter and fundus imaging devices under the iCare brand. The company also offers the Oculo software platform for clinical communication, telehealth, remote patient monitoring, and data analytics. With international operations, it serves markets in Finland, the United States, and other regions.